ГОСТ Р MCO/HL7 27931-2015
OBR|3 |932АОЕ|2437 89АLAB|88304ASURG PATH REPORTI| | 19940101| . . .<cr>
ОВХ| 1 ICE I88304&ANTI 1 | 9999APANCREASASNM| . . .<cr>
ОВХ |2 ICE |88 304 &IMP |2 | 9999AADENOCARCINOMAASNM| . . .<cr>
OBR|4 |933AOE|2437 90ALAB|85022ЛСВС|I I 199412050800 I . . .<cr>
OBX| 1 |
№4
|718-7 AHEMOGLOBIN:
ALN
| 113.4 |GI4/DL | 14-18 |N| |
S
I F 11986052 2 | . . .<cr>
(Результат общего анализа крови)
ОВХ| 2 |N14|45 44 -3AHEMATOCRIT : ALN| | 40.3 I %I42-52 |L| |SI F 119860522 | . . .<cr>
OBX
| 3
|NM|789-8AERYTHROCYTES:AL N ||4 .5 6 |10»6 /m l
|
4 .7 - 6 .1 |L |
|
S
I F |
19860522
|
. .
.<cr>
OBX| 4 |NM| 78 7-22AERYTHROCYTE MEAN CORPUSCULAR VOLUME:AL N ||83| £1| 80-
9 4 | N | | S |
F |
19860522
| . ..<cr>
OBX|5 |NM|78 5-6 AERYTHROCYTE MEAN CORPUSCULAR HEMOGLOBIN: ALNI | 29.5 Ipq|27-
3 1 |N| | N | F | 198605221...<cr>
OBX|6 |№4| 786-4AERYTHROCYTE MEAN CORPUSCULAR HEMOGLOBIN
CONCENTRATION:ALN| | 33 I %I 33-37 IN| IN|F |19860522| . . .<cr>
OBX|7|NM|6690-2ALEUKOCYTES:ALN| | 10. 7 110*3/m l I 4 . 8 -1 0 . 8 |N| |N| F 119860522| . ..<cr>
OBX|8 INM|764-1ANEUTROPHILS
OBX|9 INM|76 9-0 ANEUTROPHILS
BAND FORM/100
SEGMENTED/100
LEUKOCYTES: ALN| | 2 |%| | | | |F | . . . <cr>
LEUKOCYTES: ALN| | 67| %| | | | |F | . . . < c r >
OBX|10|NM|7 36-9ALYMPHOCYTES/100 LEUKOCYTES: ALN
||
291
%
I I
|j j F|
. . .<cr>
OBX|11 1NM|5 905-5 AMONOCYTES/10 0 LEUKOCYTES: ALN| | 1 |%| III IF| . . .<cr>
OBX|12|NM|713-8AEOSINOPHILS/100 LEUKOCYTES: AL N | | 2 | % | | | | | F | . . .<cr>
OBR|5 I934AOE|2437 91ALAB|80004AELECTROLYTESI I I 199412050800| .. .<cr>
OBX|1 |NM|2947-0ASODIUM:AL N ||150|m m o l/l|1 3 6 -1 4 8 |H ||A |F |19850301 I . . .<cr>
OBX|2 |NM|2823-3APOTASSIUM:
a
L N ||4 . 5 |m m o l/l|3 . 5 - 5 |N ||N |F |19850301| . . .<cr>
OBX | 2 INM|DRUGDISPAC a p s u l e s
OBX | 3 |NM|DRUGRETNAC a p s u l e s
D i s p e n s e d AN C 1 1 |6 0 | . . . < c r >
R e t u r n e d ANCI| |5 | . . .< c r >
(Концентрация электролитов)
OBX| 3 |NM|20 6 9 - 3 ACHLORIDE:ALN| 1102 |m m ol/ Ц 9 4 -1 0 5 |N| | N | F 1 1 9 8 5 0 3 0 1 1. . , < c r >
OBXI 4 |NM |20 2 8 - 9ACARBON DIOXIDE.TOTAL:ALN| | 2 7 |m m o l / 1 12 4 - 3 1 1N | | N | F
1 1 9 8 5 0 3 0 Ц . . . < c r >
C S P |AC o u r s e 1 11 9 9 4 1 2 0 5 I 1 9 9 5 0 1 2 0 IYAT o x i c i t y a n d R e s p o n s e ANCI | . . . < c r >
C S S |AC o u r s e C o m p l e t i o n ! 1 9 9 5 0 1 2 0 1 . . . < c r >
OBR11 | 935AOE|2 43791ALAB|2039-6ACARCINOEMBRYONIC AG:ALN| | 1199410 08| ...< c r>
OBX|1|NM|2039-6ACARCINOEMBRYONIC AG:ALN| | 15.2 | IU | . . . < c r >
OBR|2 11 2 3 6 | 1 2 3 6 110AC o u r s e C o m p l e t i o n Form AS t u d y P h a s e F o r m s L i s t I I 119950120
I . . .
<cr>
OBX | 1 1CE|CRSRESPAC o u r s e R e s p o n s e ANCII I4 AP a r t i a l R e s p o n s e l . , . < c r>
OBX | 4 |ID|DXCQMPAD i a g n o s t i c T e s t s C o m p l i a n c e AN C I | | Y | . . . < c r>
OBX | 5 ICE|PERSTATAP e r i o r m a n c e S t a t u s ANCI| | 3 AZUBRODS| . . . < c r>
OBR |
3112371123719999AAdverse Events I ...
< c r >
[Примечания
OBX |
1 |CE|9999&EVENTI1 | 45AVomitingAN C I|,
. .< c r >
1 необходимо
OBX |
2 |DT|9999&ONSETI1 1199412151. . .<cr>обеспечить
OBX |
3 |DT|9999&RESOLUTION|1 |19941217|..,
< c r>
совместимость с
пр од олжающейс я
разработкой
сообщений, связанных
с передачей данных о
нежелательных
реакциях. ]
1419